PharmStars
PharmStars is a Boston-based digital health accelerator that runs themed 10-week PharmaU cohorts twice yearly, educating startups and providing paying pharma members like Boehringer Ingelheim, Eli Lilly, Takeda, and Roche with curated access to startups through a private Showcase Event.
- Company typePrivate
- Founded2021
- HeadquartersBoston, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What PharmStars does
PharmStars is a Boston-based, pharma-focused accelerator for digital health startups founded in June 2021 by Naomi Fried, PhD and Laura Gunn, PhD. The company operates a 10-week themed cohort program called PharmaU, run twice per year (Spring and Fall), with each cohort focused on a specific therapeutic or operational area such as Oncology, Clinical Trials, Rare Disease, Women's Health, Real-World Evidence, Immunology, and Operations & Outcomes. The program combines a structured pharma curriculum, individualized mentoring from in-house former pharma executives, and an Executive Ed component for pharma leadership, culminating in a private Startup Showcase Event held in Boston where graduates pitch to and hold one-on-one meetings with paying pharma members.
PharmStars monetizes primarily through annual pharma membership fees paid by enterprise pharmaceutical firms — publicly identified members include Boehringer Ingelheim, Eli Lilly, Takeda (founding 2021), Roche (2022), and Sumitovant Biopharma — in exchange for exclusive, curated access to the startup cohort pipeline. Digital health startups apply globally through a competitive selection process and participate in cohorts that have attracted applicants from 40+ countries. In 2025 the firm extended its model with the launch of PharmStars Ventures, a venture fund co-founded by Naomi Fried and Shrawan Patel, MD as General Partners that invests exclusively in accelerator alumni and holds 23+ portfolio positions. The broader operating stack includes Graduate School programming for ongoing alumni engagement and, as of May 2026, the inaugural PharmTech Innovation Summit in Boston.
Across ten completed cohorts, PharmStars has graduated 112+ digital health startups with a 99% completion rate; alumni have collectively raised over $1B in funding and, among the first 35 graduates, have secured 100+ pharma deals. The firm is headquartered at 661 Commonwealth Avenue, Newton, Massachusetts, operates with a small team of under 10 employees, and has no publicly disclosed institutional funding rounds, indicating it has been funded primarily through operating revenues from pharma membership.
PharmStars firmographics
Firmographics- Name
- PharmStars
- Legal name
- PharmStars
- Website
- https://pharmstars.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PharmStars is a Boston-based digital health accelerator that runs themed 10-week PharmaU cohorts twice yearly, educating startups and providing paying pharma members like Boehringer Ingelheim, Eli Lilly, Takeda, and Roche with curated access to startups through a private Showcase Event.
- Ownership category
- akta.pro rank
PharmStars industry classification
Industry- Product category
- Digital Health Accelerator Services
- NAICS
- Business Schools and Computer and Management Training (6114)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Corporate Accelerators & Startup Programs (FSANAHAD)
- akta.pro secondary industry
- Pharmaceuticals & Biotechnology (EDABALAU)
Keywords
Where PharmStars is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PharmStars business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Pharma Membership Fees: Pharma companies pay membership fees to join PharmStars, gaining exclusive access to curated digital health startups, participation in the Showcase Event, and engagement through Executive Ed programming. Pharma members commit to working with startups that graduate from the accelerator.
- Accelerator Program Participation Fees: Digital health startups apply and are selected to participate in the 10-week PharmaU cohort. While specific tuition is not publicly disclosed, startups benefit from education, mentoring, and direct access to pharma members at the Showcase Event.
- PharmStars Ventures Investment Returns: PharmStars Ventures, a venture fund wrapping around the accelerator, invests in PharmStars alumni companies. Returns on investment in portfolio companies generate revenue for the fund's general partners.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Pharma Membership — access to curated startups, Showcase Event, Executive Ed, and one-on-one meetings |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
PharmStars product offering
Product offeringCore offering
PharmStars operates a 10-week PharmaU accelerator program for digital health startups, providing a structured pharma-focused curriculum covering drug development, regulatory drivers, and pharma-startup deal structures. The program includes individualized mentoring from former pharma executives, executive education for pharma members, and culminates in a private Startup Showcase event where startups pitch to and meet one-on-one with multiple pharma companies. Additional offerings include the Graduate School alumni program and PharmStars Ventures, a venture fund investing in accelerator graduates.
Product overview
PharmStars is a pharma-focused accelerator for digital health startups, offering a 10-week accelerator program as its core offering. The main product is PharmaU, an educational program with three components: a curriculum for startups, personalized mentoring, and Executive Education for pharma leadership. The accelerator culminates with a Startup Showcase event. Additional offerings include PharmStars Ventures (a venture fund for graduates) and Graduate School (ongoing alumni support).
Differentiator
Problem solved
Functional benefit
Brands
- PharmaU: The centerpiece educational program of PharmStars accelerator consisting of curriculum for startups, mentoring, and Executive Education for pharma leadership
- PharmStars Ventures
- Graduate School
- Executive Ed
Products and services
- PharmStars Accelerator (PharmaU Program)
- Startup Showcase Event
- PharmStars Ventures
- Graduate School
- PharmTech Innovation Summit
Quantifiable outcome
- 99% graduation rate across all cohorts
- +5 more outcomes
Companies that use PharmStars
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles2 records
PharmStars technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
PharmStars partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- RochecoreRoche joined PharmStars as a pharma member, gaining exclusive access to curated digital health startups through the Showcase Event and ongoing engagement with the accelerator's alumni community.
- Sumitovant BiopharmacoreSumitovant Biopharma joined PharmStars as a member, participating in the accelerator to connect with digital health startups. Sumitovant's Chief Medical Officer Sam Azoulay also serves as a Mentor Advisor to PharmStars.
- Boehringer IngelheimcoreBoehringer Ingelheim is a founding member of PharmStars, participating as a pharma member since the accelerator's public launch in June 2021. As a member, Boehringer Ingelheim gains access to curated digital health startups for potential partnerships and collaboration.
- Eli Lilly and CompanycoreEli Lilly and Company is a founding member of PharmStars, participating as a pharma member since the accelerator's public launch in June 2021. Lilly engages with startups through the Showcase Event and one-on-one meetings, exploring digital health partnerships aligned with its innovation strategy.
- TakedacoreTakeda is a founding member of PharmStars, participating as a pharma member since the accelerator's public launch in June 2021. Takeda engages with PharmStars startups to explore digital health solutions that complement its therapeutic focus areas.
Scale indicators8 records
Recent moves8 records
Expansion highlights6 records
PharmStars competitors and assessment
Company assessmentDirect peers
- Novartis Biome: Novartis' digital health innovation hub runs accelerator-style programs that connect digital health startups with pharma stakeholders. Direct competition for digital health startups seeking pharma partnerships.
- Bayer G4A: Bayer's digital health accelerator offers pharma-sponsored programming for health startups and is a direct competitor for both pharma member mind-share and startup applicants. Comparable cohort-based model connecting pharma with digital health ventures.
- Johnson & Johnson Innovation – JLABS: J&J's life sciences incubator network operates pharma-backed accelerator programming across multiple therapeutic areas. Highly comparable in serving as a neutral pharma-adjacent platform for healthcare startups seeking enterprise partnerships.
- Pfizer Healthcare Hub: Pfizer's healthcare hub supports digital health and patient-centric startups through partnership programming. Comparable pharma-led accelerator targeting the same startup-pharma engagement gap.
- Merck Digital Sciences Studio: Merck's digital sciences studio incubates biotech and digital health startups with pharma resources. Similar model offering pharma-backed infrastructure and mentorship to digital health ventures.
- MassChallenge HealthTech: HealthTech-focused accelerator partnering with industry sponsors to drive digital health innovation. Comparable cohort-based model serving startups seeking enterprise healthcare partnerships.
- Plug and Play Health: Corporate-backed accelerator program with a dedicated health vertical running themed batches for digital health startups. Comparable cohort structure and pharma/healthcare member model.
- Startupbootcamp Digital Health: Global digital health accelerator running cohort-based programs for early-stage healthcare ventures with corporate partner access. Direct competition for digital health startup applicants.
Others
- HIMSS (Healthcare Information and Management Systems Society): Healthcare IT industry organization with innovation programming, accelerators, and venture connections. Adjacent ecosystem participant that serves similar audiences (pharma, digital health startups, providers) and overlaps with PharmStars' market.
- Healthtech Alliance: Healthcare technology industry alliance connecting startups with healthcare enterprise stakeholders. Comparable in facilitating enterprise-startup partnerships in the digital health space.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
PharmStars social profiles
Digital presencePharmStars financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmStars leadership team
Management profileNumber of profiles
Profiles5 records
PharmStars subsidiaries and ownership
Company hierarchySubsidiaries1 record
PharmStars funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmStars M&A and investment
M&A and investmentM&A
Investments69 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmStars
What does PharmStars do?
PharmStars operates a 10-week PharmaU accelerator program for digital health startups, providing a structured pharma-focused curriculum covering drug development, regulatory drivers, and pharma-startup deal structures. The program includes individualized mentoring from former pharma executives, executive education for pharma members, and culminates in a private Startup Showcase event where startups pitch to and meet one-on-one with multiple pharma companies. Additional offerings include the Graduate School alumni program and PharmStars Ventures, a venture fund investing in accelerator graduates.
Is PharmStars a public or private company?
PharmStars is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PharmStars founded?
PharmStars was founded in 2021. It employs 1 to 10 people.
Where is PharmStars based?
PharmStars is headquartered in Boston, United States, in the North America region.
How does PharmStars make money?
Three revenue lines are on record. Pharma Membership Fees are the primary driver. The others are accelerator Program Participation Fees and pharmStars Ventures Investment Returns.
Who are PharmStars's main competitors?
Direct peers on record are Novartis Biome, Bayer G4A, Johnson & Johnson Innovation – JLABS, Pfizer Healthcare Hub, Merck Digital Sciences Studio, MassChallenge HealthTech, Plug and Play Health and Startupbootcamp Digital Health. Others are HIMSS (Healthcare Information and Management Systems Society) and Healthtech Alliance.
Does PharmStars have an API?
No public API is recorded for PharmStars.
What industry is PharmStars in?
PharmStars's product category is Digital Health Accelerator Services. Its primary akta.pro industry code is FSANAHAD, Corporate Accelerators & Startup Programs, with a secondary code of EDABALAU, Pharmaceuticals & Biotechnology. Its NAICS code is 6114 and its SIC code is 8742.